Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 176 - 200 of 338 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Diacylglycerophosphoinositolglycans LMGP15010109
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/18:1(9Z))
126457477 1336.715608 C62H113O28P
Diacylglycerophosphoinositolglycans LMGP15010130
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/16:1(9Z))
126457498 1336.715608 C62H113O28P
Diacylglycerophosphoinositolglycans LMGP15010135
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:0)
126457503 1336.715608 C62H113O28P
Diacylglycerophosphoinositolglycans LMGP15010131
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/16:2(9Z,12Z))
126457499 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010136
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:1(9Z))
126457504 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010141
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:0)
126457509 1334.699958 C62H111O28P
Diacylglycerophosphoinositolglycans LMGP15010137
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/16:2(9Z,12Z))
126457505 1332.684308 C62H109O28P
Diacylglycerophosphoinositolglycans LMGP15010142
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:1(9Z))
126457510 1332.684308 C62H109O28P
Diacylglycerophosphoinositolglycans LMGP15010143
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/16:2(9Z,12Z))
126457511 1330.668658 C62H107O28P
Diacylglycerophosphoinositolglycans LMGP15010102
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/18:0)
126457470 1324.715608 C61H113O28P
Diacylglycerophosphoinositolglycans LMGP15010111
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/16:0)
126457479 1324.715608 C61H113O28P
Diacylglycerophosphoinositolglycans LMGP15010103
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/18:1(9Z))
126457471 1322.699958 C61H111O28P
Diacylglycerophosphoinositolglycans LMGP15010112
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/16:1(9Z))
126457480 1322.699958 C61H111O28P
Diacylglycerophosphoinositolglycans LMGP15010117
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:0)
126457485 1322.699958 C61H111O28P
Diacylglycerophosphoinositolglycans LMGP15010113
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/16:2(9Z,12Z))
126457481 1320.684308 C61H109O28P
Diacylglycerophosphoinositolglycans LMGP15010118
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:1(9Z))
126457486 1320.684308 C61H109O28P
Diacylglycerophosphoinositolglycans LMGP15010123
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:0)
126457491 1320.684308 C61H109O28P
Diacylglycerophosphoinositolglycans LMGP15010119
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:2(9Z,12Z))
126457487 1318.668658 C61H107O28P
Diacylglycerophosphoinositolglycans LMGP15010124
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:1(9Z))
126457492 1318.668658 C61H107O28P
Diacylglycerophosphoinositolglycans LMGP15010125
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:2(9Z,12Z))
126457493 1316.653008 C61H105O28P
Diacylglycerophosphoinositolglycans LMGP15010105
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:0)
126457473 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010128
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/14:0)
126457496 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010106
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:1(9Z))
126457474 1308.684308 C60H109O28P
Diacylglycerophosphoinositolglycans LMGP15010134
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/14:0)
126457502 1308.684308 C60H109O28P
Diacylglycerophosphoinositolglycans LMGP15010107
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:2(9Z,12Z))
126457475 1306.668658 C60H107O28P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024